Hepatitis B trials in South Korea
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePhase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
- Where
- Seoul
- Age
- 18 years to 65 years
- People
- 84 worldwide
- Run by
- AusperBio Therapeutics Inc.
See details and how to joinNCT07370207 - Phase 1Taking peopleA Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- Where
- Seogu, Songpa-dong
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- GigaGen, Inc.
See details and how to joinNCT07024641 - No phaseEnrolling by invitationProphylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation
- Where
- Seoul
- Age
- 19 years to 70 years
- People
- 226
- Run by
- Seoul St. Mary's Hospital
See details and how to joinNCT04942886 - Phase 3Taking peopleA Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
- Where
- Busan, Daejeon, Goyang-si, Seoul, Suwon
- Age
- 18 years to 64 years
- People
- 105
- Run by
- GC Biopharma Corp
See details and how to joinNCT05686759 - No phaseTaking peopleLong-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
- Where
- Seoul
- Age
- 20 years to 70 years
- People
- 50 worldwide
- Run by
- Arbutus Biopharma Corporation
See details and how to joinNCT06277037